Caspase-4 activation in association with decreased adenosine deaminase activity may be a factor for gastric ulcer

Takahiro Yaguchi1, Masaru Saito, Yoshiyuki Yasuda

  • 1Division of Bioinformation, Department of Physiology, Hyogo College of Medicine, Nishinomiya, Japan.

Digestion
|December 24, 2009
PubMed
Abstract

Insights

Reduced adenosine deaminase (ADA) activity in the stomach may cause gastric ulcers by increasing adenosine levels, leading to cell apoptosis via caspase-4 and caspase-3 activation. This reveals a novel pathway for gastric ulcer pathogenesis.

Area of Science:

  • Biochemistry
  • Immunology
  • Gastroenterology

Background:

  • Adenosine deaminase (ADA)-deficient disease, a form of severe combined immunodeficiency, is linked to gastrointestinal issues like ulcers.
  • The specific role of ADA in the development of gastric ulcers requires further investigation.

Purpose of the Study:

  • To explore the involvement of ADA in the pathogenesis of gastric ulcers.
  • To investigate the correlation between ADA activity, adenosine levels, and gastric epithelial cell apoptosis.

Main Methods:

  • Measured ADA activity in rat tissues and human gastric biopsy samples.
  • Utilized MTT assay, TUNEL staining, and enzymatic assays for caspase-3 and -4 in MKN45 cells.
  • Performed Western blot analysis to detect caspase-4 activation in gastric biopsies.

Main Results:

  • Gastrointestinal epithelium showed higher ADA activity in rats.
  • ADA inhibition in MKN45 cells decreased viability and increased apoptosis markers (TUNEL, caspases-3, -4).
  • Gastric ulcer tissues exhibited lower ADA activity and a trend towards caspase-4 activation.

Conclusions:

  • Decreased gastric ADA activity elevates intracellular adenosine, potentially inducing gastric epithelial cell apoptosis.
  • Caspase-4 and caspase-3 activation are implicated in this ADA-related gastric ulcer pathway.
  • This study proposes a novel mechanism linking ADA activity and caspase-4 to gastric ulcer pathogenesis.

Related Concept Videos

Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds to M3...
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining. Bicarbonate,...
Peptic Ulcer Disease II: Pathophysiology01:24

Peptic Ulcer Disease II: Pathophysiology

Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...
Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...